20 results
8-K
EX-10.1
ITCI
Intra-Cellular Therapies Inc
5 Jan 22
Financial Statements and Exhibits
4:58pm
with release of a batch of Product, Siegfried shall provide to ITI promptly in response to its request [***].
Audits, Notification and Recall … complaints associated with Products. Siegfried shall maintain such traceability records as are sufficient and as may be necessary to permit a recall
424B3
n9v5epcwbpp8s
4 Apr 14
Prospectus supplement
12:00am
424B1
48pl gbylxqt5oz
31 Jan 14
Prospectus with pricing info
12:00am
424B3
1kneb
19 Dec 13
Prospectus supplement
12:00am
8-K/A
cyo6ywi5ub pb23z
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-10.2
6hcf7
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
S-1
1vzg18u
18 Sep 13
IPO registration
12:00am
8-K
w7lfx9f1c6ggnj
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-10.2
lex7nemxq w518in0st
5 Sep 13
Report of Independent Registered Public Accounting Firm
12:00am
- Prev
- 1
- Next